Insulin Delivery Devices Market Size, Share & Trends Analysis Report By Product (Insulin Syringes, Insulin Pens, Insulin Pumps, Insulin Injectors), By End Use (Hospitals, Homecare), By Region, And Segment Forecasts, 2022 - 2030
This report can be delivered to the clients within 72 Business Hours
Insulin Delivery Devices Market Growth & Trends
The global insulin delivery devices market size is expected to reach USD 27.7 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 7.4% from 2022 to 2030. Obesity, sedentary lifestyles, and unhealthy food habits, primarily in the young population, lead to the occurrence of diabetes. In addition, the growing diabetic geriatric population is another factor supporting the growth of this vertical. According to the United Nations, Department of Economic and Social Affairs, around 901 million individuals were aged 60 or over in 2015 and this number is projected to increase to 1.4 billion by 2030. Thus, the enlarging elderly population is expected to boost the demand for insulin delivery devices.
Technological innovations and advancements are an ongoing trend in this vertical. The high demand for advanced insulin delivery devices is supporting the adoption of recently launched innovative pen devices and portable pumps, which is estimated to boost the market growth. Also, favorable reimbursement policies for these devices, mainly in developed countries like the U.S. and Germany, are anticipated to fuel the market growth during the study period. However, stringent regulatory requirements regulating the approval of insulin delivery devices and the high cost of insulin analogs in diabetes care management are major factors restraining the growth of this industry.
The market's prominent competitors are taking different initiatives such as acquisition, funding, and product development to expand their product portfolio and enhance their manufacturing capacity. For instance, in October 2021, Eli Lilly partnered with Cipla, to market its Insulin products (Humalog and Trulicity) in India. Additionally, In June 2021, the company acquired Protomer Technologies, to strengthen its market presence. Further, Novo Nordisk, joined hands with Biocorp to develop a Bluetooth-enabled smart add-on device for their pen insulin injector.
Insulin Delivery Devices Market Report Highlights
Insulin Delivery Devices Market Growth & Trends
The global insulin delivery devices market size is expected to reach USD 27.7 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 7.4% from 2022 to 2030. Obesity, sedentary lifestyles, and unhealthy food habits, primarily in the young population, lead to the occurrence of diabetes. In addition, the growing diabetic geriatric population is another factor supporting the growth of this vertical. According to the United Nations, Department of Economic and Social Affairs, around 901 million individuals were aged 60 or over in 2015 and this number is projected to increase to 1.4 billion by 2030. Thus, the enlarging elderly population is expected to boost the demand for insulin delivery devices.
Technological innovations and advancements are an ongoing trend in this vertical. The high demand for advanced insulin delivery devices is supporting the adoption of recently launched innovative pen devices and portable pumps, which is estimated to boost the market growth. Also, favorable reimbursement policies for these devices, mainly in developed countries like the U.S. and Germany, are anticipated to fuel the market growth during the study period. However, stringent regulatory requirements regulating the approval of insulin delivery devices and the high cost of insulin analogs in diabetes care management are major factors restraining the growth of this industry.
The market's prominent competitors are taking different initiatives such as acquisition, funding, and product development to expand their product portfolio and enhance their manufacturing capacity. For instance, in October 2021, Eli Lilly partnered with Cipla, to market its Insulin products (Humalog and Trulicity) in India. Additionally, In June 2021, the company acquired Protomer Technologies, to strengthen its market presence. Further, Novo Nordisk, joined hands with Biocorp to develop a Bluetooth-enabled smart add-on device for their pen insulin injector.
Insulin Delivery Devices Market Report Highlights
- The insulin pens segment was the largest revenue-generating category of this market in 2021. The pen is equipped with self-contained cartridges and offers ease in handling and less pain while injecting insulin. The advantages of these pen devices over other products are resulting in their growing popularity, thus serving as a vital factor in contributing to the sector’s highest share in this market
- The home care segment is estimated to be the fastest-growing segment due to increased adoption of self-care diabetes management devices and the availability of simplified and user-friendly product designs for patients
- North America is the leading regional sector and accounted for the largest revenue share in 2021 primarily due to the favorable reimbursement scenario in this space. Also, the presence of major manufacturers in this region is supporting market growth
- In Asia Pacific, the market is anticipated to grow fast during the forecast period. The high prevalence rate of diabetes in countries, such as China and India, is a major factor contributing to market expansion in this region
CHAPTER 1. METHODOLOGY AND SCOPE
1.1. Market Segmentation & Scope
1.1.1. Product
1.1.2. End use
1.1.3. Regional scope
1.1.4. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. GVR’s internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.3.5.1. Data for primary interviews in North America
1.3.5.2. Data for primary interviews in Europe
1.3.5.3. Data for primary interviews in Asia Pacific
1.3.5.4. Data for primary interviews in Latin America
1.3.5.5. Data for Primary interviews in MEA
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity flow analysis (Model 1)
1.6.1.1. Approach 1: Commodity flow approach
1.6.2. Volume price analysis (Model 2)
1.6.2.1. Approach 2: Volume price analysis
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
1.9.1. Objective
1.9.2. Objective
CHAPTER 2. EXECUTIVE SUMMARY
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Product
2.2.2. End use outlook
2.2.3. Regional outlook
2.3. Competitive Insights
CHAPTER 3. INSULIN DELIVERY DEVICES MARKET VARIABLES, TRENDS & SCOPE
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Industry Value Chain Analysis
3.3.1. Reimbursement framework
3.4. Market Dynamics
3.4.1. Market driver analysis
3.4.1.1. Increasing prevalence of diabetes
3.4.1.2. Favorable government reimbursement scenario
3.4.2. Market restraint analysis
3.4.2.1. High cost of insulin products
3.5. Insulin Delivery Devices Market Analysis Tools
3.5.1. Industry Analysis - Porter’s
3.5.1.1. Supplier power
3.5.1.2. Buyer power
3.5.1.3. Substitution threat
3.5.1.4. Threat of new entrant
3.5.1.5. Competitive rivalry
3.5.2. PESTEL Analysis
3.5.2.1. Political landscape
3.5.2.2. Technological landscape
3.5.2.3. Economic landscape
3.5.3. Major Deals & Strategic Alliances Analysis
3.5.4. Market Entry Strategies
CHAPTER 4. INSULIN DELIVERY DEVICES MARKET: PRODUCT ESTIMATES & TREND ANALYSIS
4.1. Definitions and Scope
4.1.1. Insulin syringes
4.1.2. Insulin pens
4.1.3. Insulin pumps
4.1.4. Insulin injectors
4.2. Product Market Share, 2018 & 2030
4.3. Segment Dashboard
4.4. Global Insulin Delivery Devices Market by Product Outlook
4.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
4.5.1. Insulin syringes
4.5.1.1. Insulin syringes market estimates and forecast, 2018 to 2030 (USD Million)
4.5.2. Insulin pens
4.5.2.1. Insulin pens market estimates and forecast, 2018 to 2030 (USD Million)
4.5.3. Insulin pumps
4.5.3.1. Insulin pumps market estimates and forecast, 2018 to 2030 (USD Million)
4.5.4. Insulin injectors
4.5.4.1. Insulin injectors market estimates and forecast, 2018 to 2030 (USD Million)
CHAPTER 5. INSULIN DELIVERY DEVICES MARKET: END-USE ESTIMATES & TREND ANALYSIS
5.1. Definitions and Scope
5.1.1. Hospitals
5.1.2. Homecare
5.1.3. Others
5.2. End Use Market Share, 2018 & 2030
5.3. Segment Dashboard
5.4. Global Insulin Delivery Devices Market by End Use Outlook
5.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
5.5.1. Hospitals
5.5.1.1. Hospitals estimates and forecast, 2018 to 2030 (USD Million)
5.5.2. Home care
5.5.2.1. Home care market estimates and forecast, 2018 to 2030 (USD Million)
5.5.3. Others
5.5.3.1. Others market estimates and forecast, 2018 to 2030 (USD Million)
CHAPTER 6. INSULIN DELIVERY DEVICES MARKET: REGIONAL ESTIMATES & TREND ANALYSIS
6.1. Regional market share analysis, 2018 & 2030
6.2. Regional Market Dashboard
6.3. Global Regional Market Snapshot
6.4. Regional Market Share and Leading Players
6.4.1. North America
6.4.2. Europe
6.4.3. Asia Pacific
6.4.4. Latin America
6.4.5. Middle East and Africa
6.5. SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
6.5.1. North America
6.5.2. Europe
6.5.3. Asia Pacific
6.5.4. Latin America
6.5.5. Middle East and Africa
6.6. Market Size, & Forecasts, Volume and Trend Analysis, 2018 to 2030
6.7. North America
6.7.1. Market estimates and forecast, 2018 - 2030 (USD Million)
6.7.2. U.S.
6.7.2.1. Market estimates and forecast, 2018 - 2030 (USD Million)
6.7.3. Canada
6.7.3.1. Market estimates and forecast, 2018 - 2030 (USD Million)
6.8. Europe
6.8.1. U.K.
6.8.1.1. Market estimates and forecast, 2018 - 2030 (USD Million)
6.8.2. Germany
6.8.2.1. Market estimates and forecast, 2018 - 2030 (USD Million)
6.9. Asia Pacific
6.9.1. China
6.9.1.1. Market estimates and forecast, 2018 - 2030 (USD Million)
6.9.2. India
6.9.2.1. Market estimates and forecast, 2018 - 2030 (USD Million)
6.10. Latin America
6.10.1. Brazil
6.10.1.1. Market estimates and forecast, 2018 - 2030 (USD Million)
6.10.2. Mexico
6.10.2.1. Market estimates and forecast, 2018 - 2030 (USD Million)
6.11. MEA
6.11.1. South Africa
6.11.1.1. Market estimates and forecast, 2018 - 2030 (USD Million)
CHAPTER 7. COMPETITIVE LANDSCAPE
7.1. Recent Developments & Impact Analysis, By Key Market Participants
7.2. Company/Competition Categorization
7.2.1. Innovators
7.3. Vendor Landscape
7.3.1. List of key distributors and channel partners
7.3.2. Key customers
7.3.3. Key company market share analysis
7.3.4. Novo Nordisk A/S
7.3.4.1. Company overview
7.3.4.2. Financial performance
7.3.4.3. Product benchmarking
7.3.4.4. Strategic initiatives
7.3.5. Sanofi
7.3.5.1. Company overview
7.3.5.2. Financial performance
7.3.5.3. Product benchmarking
7.3.5.4. Strategic initiatives
7.3.6. Eli Lilly and Company
7.3.6.1. Company overview
7.3.6.2. Financial performance
7.3.6.3. Product benchmarking
7.3.6.4. Strategic initiatives
7.3.7. Biocon Ltd.
7.3.7.1. Company overview
7.3.7.2. Financial performance
7.3.7.3. Product benchmarking
7.3.7.4. Strategic initiatives
7.3.8. Ypsomed AG
7.3.8.1. Company overview
7.3.8.2. Financial performance
7.3.8.3. Product benchmarking
7.3.8.4. Strategic initiatives
7.3.9. Wockhardt Ltd.
7.3.9.1. Company overview
7.3.9.2. Financial performance
7.3.9.3. Product benchmarking
7.3.9.4. Strategic initiatives
7.3.10. Medtronic
7.3.10.1. Company overview
7.3.10.2. Financial performance
7.3.10.3. Product benchmarking
7.3.10.4. Strategic initiatives
7.3.11. Abbott Laboratories
7.3.11.1. Company overview
7.3.11.2. Financial performance
7.3.11.3. Product benchmarking
7.3.11.4. Strategic initiatives
7.3.12. F. Hoffmann-La Roche, Ltd.
7.3.12.1. Company overview
7.3.12.2. Financial performance
7.3.12.3. Product benchmarking
7.3.12.4. Strategic initiatives
1.1. Market Segmentation & Scope
1.1.1. Product
1.1.2. End use
1.1.3. Regional scope
1.1.4. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. GVR’s internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.3.5.1. Data for primary interviews in North America
1.3.5.2. Data for primary interviews in Europe
1.3.5.3. Data for primary interviews in Asia Pacific
1.3.5.4. Data for primary interviews in Latin America
1.3.5.5. Data for Primary interviews in MEA
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity flow analysis (Model 1)
1.6.1.1. Approach 1: Commodity flow approach
1.6.2. Volume price analysis (Model 2)
1.6.2.1. Approach 2: Volume price analysis
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
1.9.1. Objective
1.9.2. Objective
CHAPTER 2. EXECUTIVE SUMMARY
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Product
2.2.2. End use outlook
2.2.3. Regional outlook
2.3. Competitive Insights
CHAPTER 3. INSULIN DELIVERY DEVICES MARKET VARIABLES, TRENDS & SCOPE
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Industry Value Chain Analysis
3.3.1. Reimbursement framework
3.4. Market Dynamics
3.4.1. Market driver analysis
3.4.1.1. Increasing prevalence of diabetes
3.4.1.2. Favorable government reimbursement scenario
3.4.2. Market restraint analysis
3.4.2.1. High cost of insulin products
3.5. Insulin Delivery Devices Market Analysis Tools
3.5.1. Industry Analysis - Porter’s
3.5.1.1. Supplier power
3.5.1.2. Buyer power
3.5.1.3. Substitution threat
3.5.1.4. Threat of new entrant
3.5.1.5. Competitive rivalry
3.5.2. PESTEL Analysis
3.5.2.1. Political landscape
3.5.2.2. Technological landscape
3.5.2.3. Economic landscape
3.5.3. Major Deals & Strategic Alliances Analysis
3.5.4. Market Entry Strategies
CHAPTER 4. INSULIN DELIVERY DEVICES MARKET: PRODUCT ESTIMATES & TREND ANALYSIS
4.1. Definitions and Scope
4.1.1. Insulin syringes
4.1.2. Insulin pens
4.1.3. Insulin pumps
4.1.4. Insulin injectors
4.2. Product Market Share, 2018 & 2030
4.3. Segment Dashboard
4.4. Global Insulin Delivery Devices Market by Product Outlook
4.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
4.5.1. Insulin syringes
4.5.1.1. Insulin syringes market estimates and forecast, 2018 to 2030 (USD Million)
4.5.2. Insulin pens
4.5.2.1. Insulin pens market estimates and forecast, 2018 to 2030 (USD Million)
4.5.3. Insulin pumps
4.5.3.1. Insulin pumps market estimates and forecast, 2018 to 2030 (USD Million)
4.5.4. Insulin injectors
4.5.4.1. Insulin injectors market estimates and forecast, 2018 to 2030 (USD Million)
CHAPTER 5. INSULIN DELIVERY DEVICES MARKET: END-USE ESTIMATES & TREND ANALYSIS
5.1. Definitions and Scope
5.1.1. Hospitals
5.1.2. Homecare
5.1.3. Others
5.2. End Use Market Share, 2018 & 2030
5.3. Segment Dashboard
5.4. Global Insulin Delivery Devices Market by End Use Outlook
5.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
5.5.1. Hospitals
5.5.1.1. Hospitals estimates and forecast, 2018 to 2030 (USD Million)
5.5.2. Home care
5.5.2.1. Home care market estimates and forecast, 2018 to 2030 (USD Million)
5.5.3. Others
5.5.3.1. Others market estimates and forecast, 2018 to 2030 (USD Million)
CHAPTER 6. INSULIN DELIVERY DEVICES MARKET: REGIONAL ESTIMATES & TREND ANALYSIS
6.1. Regional market share analysis, 2018 & 2030
6.2. Regional Market Dashboard
6.3. Global Regional Market Snapshot
6.4. Regional Market Share and Leading Players
6.4.1. North America
6.4.2. Europe
6.4.3. Asia Pacific
6.4.4. Latin America
6.4.5. Middle East and Africa
6.5. SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
6.5.1. North America
6.5.2. Europe
6.5.3. Asia Pacific
6.5.4. Latin America
6.5.5. Middle East and Africa
6.6. Market Size, & Forecasts, Volume and Trend Analysis, 2018 to 2030
6.7. North America
6.7.1. Market estimates and forecast, 2018 - 2030 (USD Million)
6.7.2. U.S.
6.7.2.1. Market estimates and forecast, 2018 - 2030 (USD Million)
6.7.3. Canada
6.7.3.1. Market estimates and forecast, 2018 - 2030 (USD Million)
6.8. Europe
6.8.1. U.K.
6.8.1.1. Market estimates and forecast, 2018 - 2030 (USD Million)
6.8.2. Germany
6.8.2.1. Market estimates and forecast, 2018 - 2030 (USD Million)
6.9. Asia Pacific
6.9.1. China
6.9.1.1. Market estimates and forecast, 2018 - 2030 (USD Million)
6.9.2. India
6.9.2.1. Market estimates and forecast, 2018 - 2030 (USD Million)
6.10. Latin America
6.10.1. Brazil
6.10.1.1. Market estimates and forecast, 2018 - 2030 (USD Million)
6.10.2. Mexico
6.10.2.1. Market estimates and forecast, 2018 - 2030 (USD Million)
6.11. MEA
6.11.1. South Africa
6.11.1.1. Market estimates and forecast, 2018 - 2030 (USD Million)
CHAPTER 7. COMPETITIVE LANDSCAPE
7.1. Recent Developments & Impact Analysis, By Key Market Participants
7.2. Company/Competition Categorization
7.2.1. Innovators
7.3. Vendor Landscape
7.3.1. List of key distributors and channel partners
7.3.2. Key customers
7.3.3. Key company market share analysis
7.3.4. Novo Nordisk A/S
7.3.4.1. Company overview
7.3.4.2. Financial performance
7.3.4.3. Product benchmarking
7.3.4.4. Strategic initiatives
7.3.5. Sanofi
7.3.5.1. Company overview
7.3.5.2. Financial performance
7.3.5.3. Product benchmarking
7.3.5.4. Strategic initiatives
7.3.6. Eli Lilly and Company
7.3.6.1. Company overview
7.3.6.2. Financial performance
7.3.6.3. Product benchmarking
7.3.6.4. Strategic initiatives
7.3.7. Biocon Ltd.
7.3.7.1. Company overview
7.3.7.2. Financial performance
7.3.7.3. Product benchmarking
7.3.7.4. Strategic initiatives
7.3.8. Ypsomed AG
7.3.8.1. Company overview
7.3.8.2. Financial performance
7.3.8.3. Product benchmarking
7.3.8.4. Strategic initiatives
7.3.9. Wockhardt Ltd.
7.3.9.1. Company overview
7.3.9.2. Financial performance
7.3.9.3. Product benchmarking
7.3.9.4. Strategic initiatives
7.3.10. Medtronic
7.3.10.1. Company overview
7.3.10.2. Financial performance
7.3.10.3. Product benchmarking
7.3.10.4. Strategic initiatives
7.3.11. Abbott Laboratories
7.3.11.1. Company overview
7.3.11.2. Financial performance
7.3.11.3. Product benchmarking
7.3.11.4. Strategic initiatives
7.3.12. F. Hoffmann-La Roche, Ltd.
7.3.12.1. Company overview
7.3.12.2. Financial performance
7.3.12.3. Product benchmarking
7.3.12.4. Strategic initiatives
LIST OF TABLES
Table 1 List of Abbreviations
Table 2 North America Insulin Delivery Devices Market, by product, 2018 - 2030 (USD Million)
Table 3 North America Insulin Delivery Devices Market, by end use, 2018 - 2030 (USD Million)
Table 4 North America Insulin Delivery Devices Market, by region, 2018 - 2030 (USD Million)
Table 5 U.S. Insulin Delivery Devices Market, by product, 2018 - 2030 (USD Million)
Table 6 U.S. Insulin Delivery Devices Market, by end use, 2018 - 2030 (USD Million)
Table 7 Canada Insulin Delivery Devices Market, by product, 2018 - 2030 (USD Million)
Table 8 Canada Insulin Delivery Devices Market, by end use, 2018 - 2030 (USD Million)
Table 9 Europe Insulin Delivery Devices Market, by product, 2018 - 2030 (USD Million)
Table 10 Europe Insulin Delivery Devices Market, by end use, 2018 - 2030 (USD Million)
Table 11 Europe Insulin Delivery Devices Market, by region, 2018 - 2030 (USD Million)
Table 12 Germany Insulin Delivery Devices Market, by product, 2018 - 2030 (USD Million)
Table 13 Germany Insulin Delivery Devices Market, by end use, 2018 - 2030 (USD Million)
Table 14 U.K. Insulin Delivery Devices Market, by product, 2018 - 2030 (USD Million)
Table 15 U.K. Insulin Delivery Devices Market, by end use, 2018 - 2030 (USD Million)
Table 16 APAC Insulin Delivery Devices Market, by product, 2018 - 2030 (USD Million)
Table 17 APAC Insulin Delivery Devices Market, by end use, 2018 - 2030 (USD Million)
Table 18 APAC Insulin Delivery Devices Market, by region, 2018 - 2030 (USD Million)
Table 19 China Insulin Delivery Devices Market, by product, 2018 - 2030 (USD Million)
Table 20 China Insulin Delivery Devices Market, by end use, 2018 - 2030 (USD Million)
Table 21 India Insulin Delivery Devices Market, by product, 2018 - 2030 (USD Million)
Table 22 India Insulin Delivery Devices Market, by end use, 2018 - 2030 (USD Million)
Table 23 Latin America Insulin Delivery Devices Market, by product, 2018 - 2030 (USD Million)
Table 24 Latin America Insulin Delivery Devices Market, by end use, 2018 - 2030 (USD Million)
Table 25 Latin America Insulin Delivery Devices Market, by region, 2018 - 2030 (USD Million)
Table 26 Brazil Insulin Delivery Devices Market, by product, 2018 - 2030 (USD Million)
Table 27 Brazil Insulin Delivery Devices Market, by end use, 2018 - 2030 (USD Million)
Table 28 Mexico Insulin Delivery Devices Market, by product, 2018 - 2030 (USD Million)
Table 29 Mexico Insulin Delivery Devices Market, by end use, 2018 - 2030 (USD Million)
Table 30 Middle East and Africa Insulin Delivery Devices Market, by product, 2018 - 2030 (USD Million)
Table 31 Middle East and Africa Insulin Delivery Devices Market, by end use, 2018 - 2030 (USD Million)
Table 32 Middle East and Africa Insulin Delivery Devices Market, by region, 2018 - 2030 (USD Million)
Table 33 South Africa Insulin Delivery Devices Market, by product, 2018 - 2030 (USD Million)
Table 34 South Africa Insulin Delivery Devices Market, by end use, 2018 - 2030 (USD Million)
Table 1 List of Abbreviations
Table 2 North America Insulin Delivery Devices Market, by product, 2018 - 2030 (USD Million)
Table 3 North America Insulin Delivery Devices Market, by end use, 2018 - 2030 (USD Million)
Table 4 North America Insulin Delivery Devices Market, by region, 2018 - 2030 (USD Million)
Table 5 U.S. Insulin Delivery Devices Market, by product, 2018 - 2030 (USD Million)
Table 6 U.S. Insulin Delivery Devices Market, by end use, 2018 - 2030 (USD Million)
Table 7 Canada Insulin Delivery Devices Market, by product, 2018 - 2030 (USD Million)
Table 8 Canada Insulin Delivery Devices Market, by end use, 2018 - 2030 (USD Million)
Table 9 Europe Insulin Delivery Devices Market, by product, 2018 - 2030 (USD Million)
Table 10 Europe Insulin Delivery Devices Market, by end use, 2018 - 2030 (USD Million)
Table 11 Europe Insulin Delivery Devices Market, by region, 2018 - 2030 (USD Million)
Table 12 Germany Insulin Delivery Devices Market, by product, 2018 - 2030 (USD Million)
Table 13 Germany Insulin Delivery Devices Market, by end use, 2018 - 2030 (USD Million)
Table 14 U.K. Insulin Delivery Devices Market, by product, 2018 - 2030 (USD Million)
Table 15 U.K. Insulin Delivery Devices Market, by end use, 2018 - 2030 (USD Million)
Table 16 APAC Insulin Delivery Devices Market, by product, 2018 - 2030 (USD Million)
Table 17 APAC Insulin Delivery Devices Market, by end use, 2018 - 2030 (USD Million)
Table 18 APAC Insulin Delivery Devices Market, by region, 2018 - 2030 (USD Million)
Table 19 China Insulin Delivery Devices Market, by product, 2018 - 2030 (USD Million)
Table 20 China Insulin Delivery Devices Market, by end use, 2018 - 2030 (USD Million)
Table 21 India Insulin Delivery Devices Market, by product, 2018 - 2030 (USD Million)
Table 22 India Insulin Delivery Devices Market, by end use, 2018 - 2030 (USD Million)
Table 23 Latin America Insulin Delivery Devices Market, by product, 2018 - 2030 (USD Million)
Table 24 Latin America Insulin Delivery Devices Market, by end use, 2018 - 2030 (USD Million)
Table 25 Latin America Insulin Delivery Devices Market, by region, 2018 - 2030 (USD Million)
Table 26 Brazil Insulin Delivery Devices Market, by product, 2018 - 2030 (USD Million)
Table 27 Brazil Insulin Delivery Devices Market, by end use, 2018 - 2030 (USD Million)
Table 28 Mexico Insulin Delivery Devices Market, by product, 2018 - 2030 (USD Million)
Table 29 Mexico Insulin Delivery Devices Market, by end use, 2018 - 2030 (USD Million)
Table 30 Middle East and Africa Insulin Delivery Devices Market, by product, 2018 - 2030 (USD Million)
Table 31 Middle East and Africa Insulin Delivery Devices Market, by end use, 2018 - 2030 (USD Million)
Table 32 Middle East and Africa Insulin Delivery Devices Market, by region, 2018 - 2030 (USD Million)
Table 33 South Africa Insulin Delivery Devices Market, by product, 2018 - 2030 (USD Million)
Table 34 South Africa Insulin Delivery Devices Market, by end use, 2018 - 2030 (USD Million)
LIST OF FIGURES
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Primary interviews in North America
Fig. 5 Primary interviews in Europe
Fig. 6 Primary interviews in APAC
Fig. 7 Primary interviews in Latin America
Fig. 8 Primary interviews in MEA
Fig. 9 Market research approaches
Fig. 10 Value-chain-based sizing & forecasting
Fig. 11 QFD modeling for market share assessment
Fig. 12 Market formulation & validation
Fig. 13 Insulin Delivery Devices Market: market outlook
Fig. 14 Insulin Delivery Devices Market competitive insights
Fig. 15 Parent market outlook
Fig. 16 Related/ancillary market outlook
Fig. 17 Penetration and growth prospect mapping
Fig. 18 Industry value chain analysis
Fig. 19 Insulin Delivery Devices Market driver impact
Fig. 20 Insulin Delivery Devices Market restraint impact
Fig. 21 Insulin Delivery Devices Market strategic initiatives analysis
Fig. 22 Insulin Delivery Devices Market: product movement analysis
Fig. 23 Insulin Delivery Devices Market: product outlook and key takeaways
Fig. 24 Insulin syringes market estimates and forecast, 2018 - 2030
Fig. 25 Insulin pens market estimates and forecast, 2018 - 2030
Fig. 26 Insulin pumps market estimates and forecast, 2018 - 2030
Fig. 27 Insulin injectors market estimates and forecast, 2018 - 2030
Fig. 28 Insulin Delivery Devices Market: end-use movement analysis
Fig. 29 Insulin Delivery Devices Market: end-use outlook and key takeaways
Fig. 30 Hospitals market estimates and forecast, 2018 - 2030
Fig. 31 Homecare centers market estimates and forecast, 2018 - 2030
Fig. 32 Others market estimates and forecast, 2018 - 2030
Fig. 33 Global Insulin Delivery Devices Market: regional movement analysis
Fig. 34 Global Insulin Delivery Devices Market: regional outlook and key takeaways
Fig. 35 Global market share and leading players
Fig. 36 North America market share and leading players
Fig. 37 Europe market share and leading players
Fig. 38 Asia Pacific market share and leading players
Fig. 39 Latin America market share and leading players
Fig. 40 Middle East & Africa market share and leading players
Fig. 41 North America: SWOT
Fig. 42 Europe SWOT
Fig. 43 Asia Pacific SWOT
Fig. 44 Latin America SWOT
Fig. 45 MEA SWOT
Fig. 46 North America, by country
Fig. 47 North America
Fig. 48 North America market estimates and forecast, 2018 - 2030
Fig. 49 U.S.
Fig. 50 U.S. market estimates and forecast, 2018 - 2030
Fig. 51 Canada
Fig. 52 Canada market estimates and forecast, 2018 - 2030
Fig. 53 Europe
Fig. 54 Europe market estimates and forecast, 2018 - 2030
Fig. 55 U.K.
Fig. 56 U.K. market estimates and forecast, 2018 - 2030
Fig. 57 Germany
Fig. 58 Germany market estimates and forecast, 2018 - 2030
Fig. 59 Asia Pacific
Fig. 60 Asia Pacific market estimates and forecast, 2018 - 2030
Fig. 61 China
Fig. 62 China market estimates and forecast, 2018 - 2030
Fig. 63 India
Fig. 64 India market estimates and forecast, 2018 - 2030
Fig. 65 Latin America
Fig. 66 Latin America market estimates and forecast, 2018 - 2030
Fig. 67 Brazil
Fig. 68 Brazil market estimates and forecast, 2018 - 2030
Fig. 69 Mexico
Fig. 70 Mexico market estimates and forecast, 2018 - 2030
Fig. 71 Middle East and Africa
Fig. 72 Middle East and Africa market estimates and forecast, 2018 - 2030
Fig. 73 South Africa
Fig. 74 South Africa market estimates and forecast, 2018 - 2030
Fig. 75 Participant categorization- Insulin Delivery Devices Market
Fig. 76 Market share of key market players- Insulin Delivery Devices Market
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Primary interviews in North America
Fig. 5 Primary interviews in Europe
Fig. 6 Primary interviews in APAC
Fig. 7 Primary interviews in Latin America
Fig. 8 Primary interviews in MEA
Fig. 9 Market research approaches
Fig. 10 Value-chain-based sizing & forecasting
Fig. 11 QFD modeling for market share assessment
Fig. 12 Market formulation & validation
Fig. 13 Insulin Delivery Devices Market: market outlook
Fig. 14 Insulin Delivery Devices Market competitive insights
Fig. 15 Parent market outlook
Fig. 16 Related/ancillary market outlook
Fig. 17 Penetration and growth prospect mapping
Fig. 18 Industry value chain analysis
Fig. 19 Insulin Delivery Devices Market driver impact
Fig. 20 Insulin Delivery Devices Market restraint impact
Fig. 21 Insulin Delivery Devices Market strategic initiatives analysis
Fig. 22 Insulin Delivery Devices Market: product movement analysis
Fig. 23 Insulin Delivery Devices Market: product outlook and key takeaways
Fig. 24 Insulin syringes market estimates and forecast, 2018 - 2030
Fig. 25 Insulin pens market estimates and forecast, 2018 - 2030
Fig. 26 Insulin pumps market estimates and forecast, 2018 - 2030
Fig. 27 Insulin injectors market estimates and forecast, 2018 - 2030
Fig. 28 Insulin Delivery Devices Market: end-use movement analysis
Fig. 29 Insulin Delivery Devices Market: end-use outlook and key takeaways
Fig. 30 Hospitals market estimates and forecast, 2018 - 2030
Fig. 31 Homecare centers market estimates and forecast, 2018 - 2030
Fig. 32 Others market estimates and forecast, 2018 - 2030
Fig. 33 Global Insulin Delivery Devices Market: regional movement analysis
Fig. 34 Global Insulin Delivery Devices Market: regional outlook and key takeaways
Fig. 35 Global market share and leading players
Fig. 36 North America market share and leading players
Fig. 37 Europe market share and leading players
Fig. 38 Asia Pacific market share and leading players
Fig. 39 Latin America market share and leading players
Fig. 40 Middle East & Africa market share and leading players
Fig. 41 North America: SWOT
Fig. 42 Europe SWOT
Fig. 43 Asia Pacific SWOT
Fig. 44 Latin America SWOT
Fig. 45 MEA SWOT
Fig. 46 North America, by country
Fig. 47 North America
Fig. 48 North America market estimates and forecast, 2018 - 2030
Fig. 49 U.S.
Fig. 50 U.S. market estimates and forecast, 2018 - 2030
Fig. 51 Canada
Fig. 52 Canada market estimates and forecast, 2018 - 2030
Fig. 53 Europe
Fig. 54 Europe market estimates and forecast, 2018 - 2030
Fig. 55 U.K.
Fig. 56 U.K. market estimates and forecast, 2018 - 2030
Fig. 57 Germany
Fig. 58 Germany market estimates and forecast, 2018 - 2030
Fig. 59 Asia Pacific
Fig. 60 Asia Pacific market estimates and forecast, 2018 - 2030
Fig. 61 China
Fig. 62 China market estimates and forecast, 2018 - 2030
Fig. 63 India
Fig. 64 India market estimates and forecast, 2018 - 2030
Fig. 65 Latin America
Fig. 66 Latin America market estimates and forecast, 2018 - 2030
Fig. 67 Brazil
Fig. 68 Brazil market estimates and forecast, 2018 - 2030
Fig. 69 Mexico
Fig. 70 Mexico market estimates and forecast, 2018 - 2030
Fig. 71 Middle East and Africa
Fig. 72 Middle East and Africa market estimates and forecast, 2018 - 2030
Fig. 73 South Africa
Fig. 74 South Africa market estimates and forecast, 2018 - 2030
Fig. 75 Participant categorization- Insulin Delivery Devices Market
Fig. 76 Market share of key market players- Insulin Delivery Devices Market
